Pharmacy Portfolio
Oak Brook, IL · 8 funds and programs
Fund sponsor
Pharmacy Portfolio of Oak Brook, IL is named on SEC Form D filings for 8 private funds and programs since 2010, most recently on Apr 22, 2016. Together they report $83.9M raised from 443 investor positions.
- Funds and programs
- 8Filed on Form D
- Total raised
- $83.9MCumulative sales reported on Form D, all funds
- Investor positions
- 443Summed across funds; one investor may be in several
- First fund
- Mar 2010Earliest first sale or filing
- Latest Form D
- Apr 22, 2016Most recent filing by any of its funds
- Latest fund's offering
- Rule 506(b)No general advertising
Real estate funds (8)
Fund
First sale
Raised
Investors
Minimum
Offering
Pharmacy Portfolio VIII DST
Oak Brook, IL
First saleNov 2015
Raised$12.8M
Investors52
Minimum$25K
Offering506(b)
Pharmacy Portfolio VII DST
Oak Brook, IL
First saleDec 2014
Raised$14.8M
Investors44
Minimum$25K
Offering506(b)
Pharmacy Portfolio VI DST
Oak Brook, IL
First saleAug 2013
Raised$11.6M
Investors23
Minimum$25K
Offering506(b)
Pharmacy Portfolio V DST
Oak Brook, IL
First saleJan 2013
Raised$7.1M
Investors36
Minimum$25K
Offering—
Pharmacy Portfolio IV DST
Oak Brook, IL
First saleJan 2012
Raised$5.2M
Investors58
Minimum$25K
Offering—
Pharmacy Portfolio III DST
Oak Brook, IL
First saleAug 2011
Raised$5.0M
Investors70
Minimum$25K
Offering—
Pharmacy Portfolio II DST
Oak Brook, IL
First saleSep 2011
Raised$14.6M
Investors99
Minimum$25K
Offering—
Pharmacy Portfolio DST
Oak Brook, IL
First saleMar 2010
Raised$12.7M
Investors61
Minimum$100K
Offering—
Grouped by AltMountain from the company named on each Form D and the funds' names, so the list may be incomplete or include a related fund. New programs are added automatically when they file. Request a correction
From SEC filings, not verified. This page summarizes Form D filings as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the sponsor or its funds. “Raised” is cumulative sales, not current assets or performance. Full disclosures